Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMK0T9E)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Sphingosine-1-phosphate receptor 2 (S1PR2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Amiselimod	DMI7CYZ	Ulcerative colitis	DD71	Phase 2	[2]
US8975409, Example 13	DMVB42P	N. A.	N. A.	Patented	[3]
Jte 013	DMS3HNM	Discovery agent	N.A.	Patented	[1]
US8975409, Example 9(3)	DMJQOAE	N. A.	N. A.	Patented	[3]
Unii-R228S06soh	DMUHSAZ	N. A.	N. A.	Patented	[1]
US8975409, Comparative compound B	DM4S5DF	N. A.	N. A.	Patented	[3]
AUY954	DMVGIO5	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Sphingosine-1-phosphate receptor 2 (S1PR2)	TTVSMOH	S1PR2_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Sphingosine 1-phosphate receptor antagonists. US9663511.
2	Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk. Br J Pharmacol. 2017 Jan;174(1):15-27.
3	Phenyl derivative. US8975409.
4	A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem Biol. 2006 Nov;13(11):1227-34.